Applications of natural compounds in the photodynamic therapy of skin cancer

Current Medicinal Chemistry

Volumn 21, Issue 12, 2014, Pages 1371-1390

  Marrelli, M ^a   Menichini, G ^b   Provenzano, E ^c   Conforti, F ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c Operative Unit of Dermatology   (Italy)

Author keywords

Anticancer drugs; Natural compounds; Photoactive principles; Photodynamic therapy; Photosensitizers; Skin cancer

Indexed keywords

PHOTOSENSITIZING AGENT; PLANT EXTRACT;

DRUG CYTOTOXICITY; DRUG MECHANISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PHOTOTOXICITY; REVIEW; SKIN CANCER;

ANIMALS; BIOLOGICAL PRODUCTS; HUMANS; MELANOMA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PHYTOTHERAPY; SKIN NEOPLASMS;

EID: 84899826074     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986732112140319094324     Document Type: Review

References (135)

1. Moehrle, M., Outdoor sports and skin cancer. Clin. dermatol., 2008, 26(1), 12-15.
2. Jones, L.J. The Science of Phototherapy: An Introduction. Springer: Netherlands, 2005.
3. Jurkowitsch, T.; Knobler, R. In Photobiology: The Science of Life and Light. Björn, L.O., Ed.; Springer: New York, 2008, pp 577-590.
4. Mitton, D.; Ackroyd, R., A brief overview of photodynamic therapy in Europe. Photodiagn. Photodyn. Ther., 2008, 5(2), 103-111.
5. Kar, P.; Snehi, P.; Jha, P., Treatment of vitiligo with psoralen. Indian J. Dermatol. Venereol. Leprol., 1990, 56(2), 121.
6. Li, H.B.; Chen, F., Preparative isolation and purification of bergapten and imperatorin from the medicinal plant Cnidium monnieri using high-speed counter-current chromatography by stepwise increasing the flow-rate of the mobile phase. J. Chromatog. A, 2004, 1061(1), 51-54.
7. Lee, S.B.; Rasmussen, S.K., Molecular markers in some medicinal plants of the Apiaceae family. Euphytica, 2000, 114(2), 87-91.
8. Bowers, A.G., Phytophotodermatitis. Am. J. Contact Dermat., 1999, 10(2), 89-93.
9. Liu, R.; Li, A.; Sun, A., Preparative isolation and purification of coumarins from Angelica dahurica (Fisch. ex Hoffm) Benth, et Hook. f (Chinese traditional medicinal herb) by high-speed counter-current chromatography. J. Chromatog. A, 2004, 1052(1-2), 223-227.
10. Wang, T.; Jin, H.; Li, Q.; Cheng, W.; Hu, Q.; Chen, X.; Bi, K., Isolation and simultaneous determination of coumarin compounds in Radix Angelica dahurica. Chromatographia, 2007, 65(7), 477-481.
11. Roelandts, R., The history of phototherapy: Something new under the sun? J. Am. Acad. Dermatol., 2002, 46(6), 926-930.
12. Downes, A.; Blunt, T.P., On the influence of light upon protoplasm. Proceedings of the Royal Society of London, 1878, 28(190-195), 199-212.
13. Møller, K.I.; Kongshoj, B.; Philipsen, P.A.; Thomsen, V.O.; Wulf, H.C., How Finsen's light cured lupus vulgaris. Photodermatol. Photoimmunol. Photomed., 2005, 21(3), 118-124.
14. Ebermann, R.; Alth, G.; Kreitner, M.; Kubin, A., Natural products derived from plants as potential drugs for the photodynamic destruction of tumor cells. J. Photochem. Photobiol. B: Biol., 1996, 36(2), 95-97.
15. Conforti, F.; Marrelli, M.; Menichini, F.; Bonesi, M.; Statti, G.; Provenzano, E., Natural and Synthetic Furanocoumarins as Treatment for Vitiligo and Psoriasis. Curr. Drug Ther., 2009, 4(1), 38-58.
16. Samuelsson, G. Drugs of natural origin: a textbook of pharmacognosy. 5th ed. Swedish Pharmaceutical Press: Stockholm, 2004.
17. Caffieri, S., Furocoumarin photolysis: chemical and biological aspects. Photochem. Photobiol. Sci., 2002, 1(3), 149-157.
18. Pathak, M.A.; Fitzpatrick, T.B., The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD. J. Photochem. Photobiol. B: Biol., 1992, 14(1-2), 3-22.
19. Barraja, P.; Diana, P.; Montalbano, A.; Dattolo, G.; Cirrincione, G.; Viola, G.; Vedaldi, D.; Dall'Acqua, F., Pyrrolo[2,3-h]quinolinones: a new ring system with potent photoantiproliferative activity. Bioorg. Med. Chem., 2006, 14(24), 8712-8728.
20. Vrouenraets, M.B.; Visser, G.; Snow, G.; Van Dongen, G., Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res., 2003, 23(1B), 505.
21. Gold, M.H. In Photodynamic Therapy in Dermatology. Gold, M.H., Ed.; Springer: New York, 2011, pp 1-4.
22. Wolfsen, H.C., Present status of photodynamic therapy for highgrade dysplasia in Barrett's esophagus. J. Clin. Gastroenterol., 2005, 39(3), 189.
23. Bissonnette, R. In Photodynamic Therapy in Dermatology. Gold, M.H., Ed.; Springer: New York, 2011, pp 139-147.
24. Zeitouni, N.C.; Oseroff, A.; Najarian, D.J. In Skin Cancer Management A Practical Approach. MacFarlane, D.F., Ed.; Springer: New York, 2010, pp 41-56.
25. Jocham, D.; Stepp, H.; Waidelich, R., Photodynamic diagnosis in urology: state-of-the-art. Europ. Urol., 2008, 53(6), 1138-1150.
26. Castano, A.P.; Demidova, T.N.; Hamblin, M.R., Mechanisms in photodynamic therapy: part one - photosensitizers, photochemistry and cellular localization. Photodiagn. Photodyn. Ther., 2004, 1(4), 279-293.
27. Allison, R.R.; Sibata, C.H., Oncologic photodynamic therapy photosensitizers: A clinical review. Photodiagn. Photodyn. Ther., 2010, 7(2), 61-75.
28. Stylli, S.S.; Kaye, A.H., Photodynamic therapy of cerebral glioma- A review Part I-A biological basis. J. Clin. Neurosci., 2006, 13(6), 615-625.
29. Schmidt-Erfurth, U.; Hasan, T., Mechanisms of action of photodynamic therapy with verteporfin for the treatment of agerelated macular degeneration. Surv. Ophthalmol., 2000, 45(3), 195-214.
30. Ibbotson, S.; Moseley, H.; Brancaleon, L.; Padgett, M.; O'Dwyer, M.; Woods, J.; Lesar, A.; Goodman, C.; Ferguson, J., Photodynamic therapy in dermatology: Dundee clinical and research experience. Photodiagn. Photodyn. Ther., 2004, 1(3), 211-223.
31. Oleinick, N.L.; Morris, R.L.; Belichenko, I., The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem. Photobiol. Sci., 2002, 1(1), 1-21.
32. Kolarova, H.; Nevrelova, P.; Bajgar, R.; Jirova, D.; Kejlova, K.; Strnad, M., In vitro photodynamic therapy on melanoma cell lines with phthalocyanine. Toxicol. in vitro, 2007, 21(2), 249-253.
33. Castano, A.P.; Demidova, T.N.; Hamblin, M.R., Mechanisms in photodynamic therapy: Part three - Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagn. Photodyn. Ther., 2005, 2(2), 91-106.
34. Agostinis, P.; Berg, K.; Cengel, K.A.; Foster, T.H.; Girotti, A.W.; Gollnick, S.O.; Hahn, S.M.; Hamblin, M.R.; Juzeniene, A.; Kessel, D., Photodynamic therapy of cancer: An update. CA: Cancer J. Clin., 2011, 61(4), 250-81.
35. Ishizuka, M.; Abe, F.; Sano, Y.; Takahashi, K.; Inoue, K.; Nakajima, M.; Kohda, T.; Komatsu, N.; Ogura, S.; Tanaka, T., Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. Int. immunopharmacol., 2011, 11(3), 358-65.
36. Zawacka-Pankau, J.; Krachulec, J.; Grulkowski, I.; Bielawski, K.P.; Selivanova, G., The p53-mediated cytotoxicity of photodynamic therapy of cancer: recent advances. Toxicol. Appl. Pharmacol., 2008, 232(3), 487-497.
37. Detty, M.R.; Gibson, S.L.; Wagner, S.J., Current clinical and preclinical photosensitizers for use in photodynamic therapy. J. Med. Chem., 2004, 47(16), 3897-3915.
38. Dougherty, T.J.; Henderson, B.W.; Gomer, C.J.; Jori, G.; Kessel, D.; Korbelik, M.; Moan, J.; Peng, Q., Photodynamic therapy. J. Natl. Cancer Inst., 1998, 90(12), 889-905.
39. Zeitouni, N.C.; Oseroff, A.R.; Shieh, S., Photodynamic therapy for nonmelanoma skin cancers: Current review and update. Mol. immunol., 2003, 39(17-18), 1133-1136.
40. Stylli, S.S.; Kaye, A.H., Photodynamic therapy of cerebral glioma- A review Part II-Clinical studies. J. Clin. Neurosci., 2006, 13(7), 709-717.
41. Juarranz, Á.; Jaén, P.; Sanz-Rodríguez, F.; Cuevas, J.; González, S., Photodynamic therapy of cancer. Basic principles and applications. Clin. Transl. Oncoly, 2008, 10(3), 148-154.
42. Korbelik, M., Induction of tumor immunity by photodynamic therapy. J. Clin. Laser Med. Surg., 1996, 14(5), 329-334.
43. Figge, F.H.J.; Weiland, G.S.; Manganiello, L.O.J.; In: Proceeding of Soc. Exp. Biol. Med.; Society for Experimental Biology and Medicine: New York, 1948; Vol. 68, pp 640-641.
44. Croce, A.C.; Supino, R.; Lanza, K.S.; Locatelli, D.; Baglioni, P.; Bottiroli, G., Photosensitizer accumulation in spontaneous multidrug resistant cells: a comparative study with Rhodamine 123, Rose Bengal acetate and Photofrin. Photochem. Photobiol. Sci., 2002, 1(1), 71-78.
45. Castano, A.P.; Demidova, T.N.; Hamblin, M.R., Mechanisms in photodynamic therapy: part two - cellular signaling, cell metabolism and modes of cell death. Photodiagn. Photodyn. Ther., 2005, 2(1), 1-23.
46. Lang, K.; Mosinger, J.; Wagnerová, D., Photophysical properties of porphyrinoid sensitizers non-covalently bound to host molecules; models for photodynamic therapy. Coord. Chem. Rev., 2004, 248(3-4), 321-350.
47. Panzarini, E.; Inguscio, V.; Dini, L., Overview of Cell Death Mechanisms Induced by Rose Bengal Acetate-Photodynamic Therapy. Int. J. Photoenergy, 2011, Article ID 713726, (doi: 10.1155/2011/713726), Available from: http://downloads.hindawi.com/journals/ijp/2011/713726.pdf.
48. Bottiroli, G.; Croce, A.; Balzarini, P.; Locatelli, D.; Baglioni, P.; Nostro, P.L.; Monici, M.; Pratesi, R., Enzyme-assisted Cell Photosensitization: A Proposal for an Efficient Approach to Tumor Therapy and Diagnosis. The Rose Bengal Fluorogenic Substrate. Photochem. Photobiol., 1997, 66(3), 374-383.
49. Agostinis, P.; Vantieghem, A.; Merlevede, W.; de Witte, P.A.M., Hypericin in cancer treatment: more light on the way. Int. J. Biochem. Cell Biol., 2002, 34(3), 221-241.
50. Von Tappeiner, H.; Jesionek, A., Therapeutische versuche mit fluoreszierenden stoffen. Münch. Med. Wochenschr., 1903, 47, 2042-2044.
51. Lipson, R.L.; Baldes, E.J.; Olsen, A.M., The use of a derivative of hematoporhyrin in tumor detection. J. Natl. Cancer Inst., 1961, 26, 1-11.
52. Sidoroff, A.; Thaler, P., Taking treatment decisions in nonmelanoma skin cancer - The place for topical photodynamic therapy (PDT). Photodiagn. Photodyn. Ther. 2010, 7(1), 24-32.
53. Tarstedt, M.; Rosdahl, I.; Berne, B.; Svanberg, K.; Wennberg, A., A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm. Venereol., 2005, 85(5), 424.
54. Rivard, J.; Ozog, D., Henry Ford Hospital dermatology experience with Levulan Kerastick and blue light photodynamic therapy. J. Drugs Dermatol., 2006, 5(6), 556-61.
55. Telfer, N.; Colver, G.; Morton, C., Guidelines for the management of basal cell carcinoma. Brit. J. Dermatol., 2008, 159(1), 35-48.
56. Mosterd, K.; Arits, A.H.; Thissen, M.R.; Kelleners-Smeets, N.W., Histology-based treatment of basal cell carcinoma. Acta Derm. Venereol., 2009, 89(5), 454-458.
57. Choudhary, S.; Nouri, K.; Elsaie, M.L., Photodynamic therapy in dermatology: a review. Lasers Med. Sci., 2009, 24(6), 971-980.
58. Taub, A.F., Photodynamic therapy: other uses. Dermatol.Clin., 2007, 25(1), 101-110.
59. Sutedja, T.G.; Postmus, P.E., Photodynamic therapy in lung cancer. A review. J. Photochem. Photobiol. B: Biol., 1996, 36 (2), 199-204.
60. Kato, H., Photodynamic therapy for lung cancer-a review of 19 years' experience. J. Photochem.Photobiol. B: Biol., 1998, 42(2), 96-99.
61. Wildeman, M.A.M.; Nyst, H.J.; Karakullukcu, B.; Tan, B.I., Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer. Head Neck Oncol., 2009, 1, 40.
62. Hopper, C.; Niziol, C.; Sidhu, M., The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK. Oral Oncol., 2004, 40(4), 372-382.
63. Hopper, C., Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol., 2000, 1(4), 212-219.
64. Schweitzer, V.G., Photofrin-Mediated Photodynamic Therapy for Treatment of Aggressive Head and Neck Nonmelanomatous Skin Tumors in Elderly Patients. Laryngoscope, 2009, 111(6), 1091-1098.
65. Wainwright, M., Photodynamic antimicrobial chemotherapy (PACT). J. Antimicrob. Chemother., 1998, 42(1), 13.
66. Ibbotson, S.H., Adverse effects of topical photodynamic therapy. Photodermatol. Photoimmunol. Photomed., 2011, 27(3), 116-130.
67. Camerin, M.; Magaraggia, M.; Soncin, M.; Jori, G.; Moreno, M.; Chambrier, I.; Cook, M.J.; Russell, D.A., The in vivo efficacy of phthalocyanine- nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma. Eur. J. Cancer, 2010, 46(10), 1910-1918.
68. Paszko, E.; Ehrhardt, C.; Senge, M.O.; Kelleher, D.P.; Reynolds, J.V., Nanodrug applications in photodynamic therapy. Photodiagn. Photodyn. Ther., 2011, 8(1), 14-29.
69. Nyman, E.S.; Hynninen, P.H., Research advances in the use of tetrapyrrolic photosensitizers for photodynamic therapy. J. Photochem. Photobiol. B: Biol., 2004, 73(1), 1-28.
70. Boyle, R.W.; Dolphin, D., Structure and Biodistribution Relationships of Photodynamic Sensitizers. Photochem. Photobiol., 1996, 64(3), 469-485.
71. Fukuda, H.; Casas, A.; Batlle, A., Aminolevulinic acid: from its unique biological function to its star role in photodynamic therapy. Int. J. Biochem. Cell Biol., 2005, 37(2), 272-276.
72. Kacerovská, D.; Pizinger, K.; Majer, F.; míd, F., Photodynamic therapy of nonmelanoma skin cancer with topical Hypericum perforatum extract-a pilot study. Photochem. Photobiol., 2008, 84(3), 779-785.
73. Spikes, J.D.; Shen, H.R.; Kopeková, P.; Kopeek, J., Photodynamic Crosslinking of Proteins. III. Kinetics of the FMNand Rose Bengal-sensitized Photooxidation and Intermolecular Crosslinking of Model Tyrosine-containing N-(2-Hydroxypropyl) methacrylamide Copolymers. Photochem. Photobiol., 1999, 70(2), 130-137.
74. Tremblay, J.F.; Dussault, S.; Viau, G.; Gad, F.; Boushira, M.; Bissonnette, R., Photodynamic therapy with toluidine blue in Jurkat cells: cytotoxicity, subcellular localization and apoptosis induction. Photochem. Photobiol. Sci., 2002, 1(11), 852-856.
75. Dougherty, T.J.; Kaufman, J.E.; Goldfarb, A.; Weishaupt, K.R.; Boyle, D.; Mittleman, A., Photoradiation therapy for the treatment of malignant tumors. Cancer Res., 1978, 38(8), 2628-2635.
76. Awan, M.; Tarin, S., Review of photodynamic therapy. Surgeon, 2006, 4(4), 231-236.
77. Kennedy, J.; Pottier, R.; Pross, D., Photodynamic therapy with endogenous protoporphyrin: IX: Basic principles and present clinical experience. J. Photochem. Photobiol. B: Biol., 1990, 6(1-2), 143-148.
78. Biel, M.A., Photodynamic therapy and the treatment of head and neck cancers. J. Clin. Laser Med. Surg., 1996, 14(5), 239-244.
79. Peng, Q.; Warloe, T.; Berg, K.; Moan, J.; Kongshaug, M.; Giercksky, K.E.; Nesland, J.M., 5-Aminolevulinic acid-based photodynamic therapy. Cancer, 1997, 79(12), 2282-2308.
80. Beale, S. In Chlorophylls and Bacteriochlorophylls. Grimm, B.; POrra, R.J.; Rudiger, W.; Scheer, H., Eds.; sgringer: Netherlands, 2006, pp 147-158.
81. Casas, A.; Batlle, A., Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. Curr. Med. Chem. Anticancer Agents, 2002, 2(4), 465-475.
82. Fotinos, N.; Campo, M.A.; Popowycz, F.; Gurny, R.; Lange, N., 5-Aminolevulinic Acid Derivatives in Photomedicine: Characteristics, Application and Perspectives. Photochem. Photobiol., 2006, 82(4), 994-1015.
83. Casas, A.; Batlle, A., Photodynamic therapy in Argentina. Photodiagn. Photodyn. Ther., 2006, 3(4), 205-213.
84. Di Venosa, G.; Hermida, L.; Fukuda, H.; Defain, M.V.; Rodriguez, L.; Mamone, L.; MacRobert, A.; Casas, A.; Batlle, A., Comparation of liposomal formulations of ALA Undecanoyl ester for its use in photodynamic therapy. J. Photochem. Photobiol. B: Biol., 2009, 96(2), 152-158.
85. Wiegell, S.R.; Wulf, H.C., Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. J. Am. Acad.f Dermatol., 2006, 54(4), 647-651.
86. Skalkos, D.; Gioti, E.; Stalikas, C.; Meyer, H.; Papazoglou, T.G.; Filippidis, G., Photophysical properties of Hypericum perforatum L. extracts-Novel photosensitizers for PDT. J. Photochem. Photobiol. B: Biol., 2006, 82(2), 146-151.
87. Barnes, J.; Anderson, L.A.; Phillipson, J.D., St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol., 2001, 53(5), 583-600.
88. Theodossiou, T.A.; Hothersall, J.S.; De Witte, P.A.; Pantos, A.; Agostinis, P., The multifaceted photocytotoxic profile of hypericin. Mol. Ppharm., 2009, 6(6), 1775-1789.
89. Bobrov, N.; Avarga, I.; Longauer, F.; Rybárová, S.; Fedoroko, P.; Brezáni, P.; Mikovsk, P.; Mirossay, L.; Tuba, J., Histomorphological changes in murine fibrosarcoma after hypericin-based photodynamic therapy. Phytomedicine, 2007, 14(2), 172-178.
90. Liu, C.D.; Kwan, D.; Saxton, R.E.; McFadden, D.W., Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo. J. Surg. Res., 2000, 93(1), 137-143.
91. Kapsokalyvas, D.; Dimitriou, H.; Skalkos, D.; Konstantoudakis, G.; Filippidis, G.; Stiakaki, E.; Papazoglou, T.; Kalmanti, M., Does Hypericum perforatum L. extract show any specificity as photosensitizer for HL-60 leukemic cells and cord blood hemopoietic progenitors during photodynamic therapy? J. Photochem. Photobiol. B: Biol., 2005, 80(3), 208-216.
92. Stavropoulos, N.; Kim, A.; Nseyo, U.; Tsimaris, I.; Chung, T.; Miller, T.; Redlak, M.; Nseyo, U.; Skalkos, D., Hypericum perforatum L. extract-Novel photosensitizer against human bladder cancer cells. J. Photochem. Photobiol. B: Biol., 2006, 84(1), 64-69.
93. Guillet, G.; Chauret, D.; Arnason, J.T., Phototoxic polyacetylenes from Viguiera annua and adaptations of a chrysomelid beetle, Zygogramma continua, feeding on this plant. Phytochemistry, 1997, 45(4), 695-699.
94. Hudson, J.; Towers, G., Therapeutic potential of plant photosensitizers. Pharmacol. Ther., 1991, 49(3), 181-222.
95. Bui-Xuan, N.H.; Tang, P.M.K.; Wong, C.K.; Fung, K.P., Photoactivated pheophorbide-a, an active component of Scutellaria barbata, enhances apoptosis via the suppression of ERK-mediated autophagy in the estrogen receptor-negative human breast adenocarcinoma cells MDA-MB-231. J. Ethnopharmacol., 2010, 131(1), 95-103.
96. Lee, W.Y.; Lim, D.S.; Ko, S.H.; Park, Y.J.; Ryu, K.S.; Ahn, M.Y.; Kim, Y.R.; Lee, D.W.; Cho, C.W., Photoactivation of pheophorbide a induces a mitochondrial-mediated apoptosis in Jurkat leukaemia cells. J. Photochem. Photobiol. B: Biol., 2004, 75(3), 119-126.
97. Hajri, A.; Wack, S.; Meyer, C.; Smith, M.; Leberquier, C.; Kedinger, M.; Aprahamian, M., In vitro and In vivo Efficacy of Photofrin and Pheophorbide a, a Bacteriochlorin, in Photodynamic Therapy of Colonic Cancer Cells. Photochem. Photobiol., 2002, 75(2), 140-148.
98. Tang, P.; Chan, J.; Au, S.; Kong, S.K.; Tsui, S.; Waye, M.; Mak, T.; Fong, W.P.; Fung, K.P., Pheophorbide a, an active compound isolated from Scutellaria barbata, possesses photodynamic activities by inducing apoptosis in human hepatocellular carcinoma. Cancer Biol. Ther., 2006, 5(9), 1111.
99. Tang, P.; Liu, X.Z.; Zhang, D.M.; Fong, W.P.; Fung, K.P., Pheophorbide a based photodynamic therapy induces apoptosis via mitochondrial-mediated pathway in human uterine carcinosarcoma. Cancer Biol. Ther., 2009, 8(6), 533-539.
100. Dujic, J.; Kippenberger, S.; Ramirez-Bosca, A.; Diaz-Alperi, J.; Bereiter-Hahn, J.; Kaufmann, R.; Bernd, A.; Hofmann, M., Curcumin in combination with visible light inhibits tumor growth in a xenograft tumor model. Int. J. Cancer, 2009, 124(6), 1422-1428.
101. Su, C.C.; Yang, J.S.; Lu, C.C.; Chiang, J.H.; Wu, C.L.; Lin, J.J.; Lai, K.C.; Hsia, T.C.; Lu, H.F.; Fan, M.J., Curcumin inhibits human lung large cell carcinoma cancer tumour growth in a murine xenograft model. Phytother. Res., 2010, 24(2), 189-192.
102. Koon, H.; Leung, A.; Yue, K.; Mak, N.K., Photodynamic effect of curcumin on NPC/CNE2 cells. J. Environ. Pathol., Toxicol. Oncol., 2006, 25(1-2), 205.
103. Araújo, N.C.; Fontana, C.R.; Gerbi, M.E.M.; Bagnato, V.S., Overall-Mouth Disinfection by Photodynamic Therapy Using Curcumin. Photomed. Laser Surg., 2012, 30(2), 96-101.
104. Akramiene, D.; Grazeliene, G.; Didziapetriene, J.; Kevelaitis, E., Treatment of Lewis lung carcinoma by photodynamic therapy and glucan from barley. Medicina (Kaunas), 2009, 45(6), 480.
105. Núñez Montoya, S.C.; Comini, L.R.; Rumie Vittar, B.; Fernández, I.M.; Rivarola, V.A.; Cabrera, J.L., Phototoxic effects of Heterophyllaea pustulata (Rubiaceae). Toxicon, 2008, 51(8), 1409-1415.
106. Comini, L.R.; Núñez Montoya, S.C.; Sarmiento, M.; Cabrera, J.L.; Argüello, G.A., Characterizing some photophysical, photochemical and photobiological properties of photosensitizing anthraquinones. J. Photochem. Photobiol. A: Chem., 2007, 188(2), 185-191.
107. Comini, L.; Fernandez, I.; Vittar, N.; Núñez Montoya, S.; Cabrera, J.; Rivarola, V., Photodynamic activity of anthraquinones isolated from Heterophyllaea pustulata Hook f.(Rubiaceae) on MCF-7c3 breast cancer cells. Phytomedicine, 2011, 18(12), 1093-5.
108. Marles, R.J.; Hudson, J.B.; Graham, E.A.; Soucy-Breau, C.; Morand, P.; Compadre, R.L.; Compadre, C.M.; Towers, G.; Arnason, J.T., Structure-activity studies of photoactivated antiviral and cytotoxic tricyclic thiophenes. Photochem. Photobiol., 1992, 56(4), 479-487.
109. Wang, Y.; Li, X.; Li, L.H.; Meng, D.L.; Li, Z.L.; Li, N., Two new thiophenes from Echinops latifolius and their phototoxic activities. Planta Med., 2007, 73(7), 696-698.
110. Lim, S.H.; Lee, H.B.; Ho, A.S., A new naturally derived photosensitizer and its phototoxicity on head and neck cancer cells. Photochem. Photobiol., 2011, 87(5), 1152-1158.
111. Kim, K.K.I.; Kawano, Y.; Yamazaki, Y., A novel porphyrin photosensitizer from bamboo leaves that induces apoptosis in cancer cell lines. Anticancer Res., 2003, 23(3B), 2355-2361.
112. Chee, C.F.; Lee, H.B.; Ong, H.C.; Ho, A.S.H., Photocytotoxic Pheophorbide-Related Compounds from Aglaonema simplex. Chem. Biodiver., 2005, 2(12), 1648-1655.
113. Cárdenas, C.; Quesada, A.; Medina, M., Evaluation of the antiangiogenic effect of aloe-emodin. Cell. Mol. Life Sci., 2006, 63(24), 3083-3089.
114. Chen, Y.C.; Shen, S.C.; Lee, W.R.; Hsu, F.L.; Lin, H.Y.; Ko, C.H.; Tseng, S.W., Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem. Pharmacol., 2002, 64(12), 1713-1724.
115. Lee, H.Z.; Hsu, S.L.; Liu, M.C.; Wu, C.H., Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma. Eur. J. Pharmacol., 2001, 431(3), 287-295.
116. Wamer, W.G.; Vath, P.; Falvey, D.E., In vitro studies on the photobiological properties of aloe emodin and aloin A. Free Rad. Bio. Med., 2003, 34(2), 233-242.
117. Su, Y.; Sun, J.; Rao, S.; Cai, Y.; Yang, Y., Photodynamic antimicrobial activity of hypocrellin A. J. Photochem. Photobiol. B: Biol., 2011, 103(1), 29-34.
118. Zhou, L.; Zhou, J.H.; Dong, C.; Ma, F.; Wei, S.H.; Shen, J., Watersoluble hypocrellin A nanoparticles as a photodynamic therapy delivery system. Dyes Pigments, 2009, 82(1), 90-94.
119. Chio-Srichan, S.; Oudrhiri, N.; Bennaceur-Griscelli, A.; Turhan, A.G.; Dumas, P.; Refregiers, M., Toxicity and phototoxicity of Hypocrellin A on malignant human cell lines, evidence of a synergistic action of photodynamic therapy with Imatinib mesylate. J. Photochem. Photobiol. B: Biol., 2010, 99(2), 100-104.
120. Beems, E.M.; Dubbelman, T.M.A.R.; Lugtenburg, J.; Van Best, J.A.; Smeets, M.F.M.A.; Boegheim, J.P.J., Photosensitizing properties of bacteriochlorophyllin a and bacteriochlorin a, two derivatives of bacteriochlorophyll a. Photochem. Photobiol., 1987, 46(5), 639-643.
121. Koudinova, N.V.; Pinthus, J.H.; Brandis, A.; Brenner, O.; Bendel, P.; Ramon, J.; Eshhar, Z.; Scherz, A.; Salomon, Y., Photodynamic therapy with Pd-bacteriopheophorbide (TOOKAD): Successful in vivo treatment of human prostatic small cell carcinoma xenografts. Int. J. Cancer, 2003, 104(6), 782-789.
122. Kamal, N.; Sabaratnam, V.; Abdullah, N.; Ho, A.S.H.; Teo, S.H.; Lee, H.B., Light-activated cytotoxic compounds from Malaysian microorganisms for photodynamic therapy of cancer. Antonie Van Leeuwenhoek, 2009, 95(2), 179-188.
123. Ong, C.Y.; Ling, S.K.; Ali, R.M.; Chee, C.F.; Samah, Z.A.; Ho, A.S.H.; Teo, S.H.; Lee, H.B., Systematic analysis of in vitro photocytotoxic activity in extracts from terrestrial plants in Peninsula Malaysia for photodynamic therapy. J. Photochem. Photobiol. B: Biol., 2009, 96(3), 216-222.
124. Gasparetto, A.; Lapinski, T.F.; Zamuner, S.R.; Khouri, S.; Alves, L.P.; Munin, E.; Salvador, M.J., Extracts from Alternanthera maritima as natural photosensitizers in photodynamic antimicrobial chemotherapy (PACT). J. Photochem. Photobiol. B: Biol., 2010, 99(1), 15-20.
125. Salvador, M.J.; Pereira, P.S.; França, S.C.; Candido, R.C.; Ito, I.Y.; Dias, D.A., Comparative study of antibacterial and antifugal activity of callus culture and adult plants extracts from Alternanthera maritima (Amaranthaceae). Braz. J.Microbiol., 2004, 35(1-2), 131-136.
126. Zohary, M. Flora Palaestina. Goldberg: Jerusalem, 1972.
127. Tutin, T.G.; Heywood, V.H.; Valentine, D.H.; Burges, N.A.; Moore, D.M.; Walters, S.M.; Webb, D.A.; Ball, W.; A.O., C.; I.K., F. Flora Europaea. Cambridge University Press: London, 1968.
128. Menichini, G.; Alfano, C.; Provenzano, E.; Marrelli, M.; Statti, G.; Menichini, F.; Conforti, F., Cachrys pungens Jan inhibits human melanoma cell proliferation through photo-induced cytotoxic activity. Cell Prolif., 2012, 45(1), 39-47.
129. Leung, H.W.C.; Hour, M.J.; Chang, W.T.; Wu, Y.C.; Lai, M.Y.; Wang, M.Y.; Lee, H.Z., P38-associated pathway involvement in apoptosis induced by photodynamic therapy with Lonicera japonica in human lung squamous carcinoma CH27 cells. Food Chem. Toxicol., 2008, 4(11), 3389-3400.
130. Joseph; Raj, J., Pharmacognostic and phytochemical properties of Ficus carica Linn - an overview. Int. J. PharmTech Res., 2011, 3(1), 08-12.
131. Marrelli, M.; Menichini, F.; Statti, G.A.; Bonesi, M.; Duez, P.; Conforti, F., Changes in the phenolic and lipophilic composition, in the enzyme inhibition and antiproliferative activity of Ficus carica L. cultivar Dottato fruits during maturation. Food Chem. Toxicol., 2012, 50(3-4), 726-33.
132. Menichini, G.; Alfano, C.; Provenzano, E.; Marrelli, M.; Statti, G.; Somma, F.; Menichini, F.; Conforti, F., Fig latex (Ficus carica L. cultivar Dottato) in combination with UV irradiation decreases the viability of A375 melanoma cells in vitro. Anticancer Agents Med. Chem., 2012, 12(8), 959-965.
133. Poiroux, G.; Pitié, M.; Culerrier, R.; Lafont, E.; Ségui, B.; Van Damme, E.J.M.; Peumans, W.J.; Bernadou, J.; Levade, T.; Rougé, P., Targeting of T/Tn Antigens with a Plant Lectin to Kill Human Leukemia Cells by Photochemotherapy. PLoS One, 2011, 6(8), e23315.
134. Folkes, L.K.; Wardman, P., Enhancing the efficacy of photodynamic cancer therapy by radicals from plant auxin (indole-3-acetic acid). Cancer Res., 2003, 63(4), 776.
135. Nagy, E.M.; Dalla Via, L.; Ronconi, L.; Fregona, D., Recent Advances in PUVA Photochemotherapy and PDT for the Treatment of Cancer. Curr. Pharm. Des., 2010, 16(16), 1863-1876.